Blockade of atrial angiotensin II type 1 receptors - A novel antiarrhythmic strategy to prevent atrial fibrillation?

被引：16
|
作者：
Klein, HU [1 ]
Goette, A [1 ]
机构：
[1] Univ Hosp Magdeburg, Dept Internal Med, Div Cardiol, D-39120 Magdeburg, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(03)00469-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2205 / 2206
页数：2
相关论文
共 50 条
  • [31] Class I, II and III antiarrhythmic drugs can not prevent electrical remodeling of human atrial fibrillation
    Yu, WC
    Chen, SA
    Chiang, CE
    Tai, CT
    Chang, MS
    CIRCULATION, 1997, 96 (08) : 413 - 413
  • [32] Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
    Jansen, Hailey. J. J.
    McRae, Megan. D. D.
    Mackasey, Martin
    Rose, Robert. A. A.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [33] Effects of angiotensin receptor blockade on atrial remodeling and the "second factor" in a goat model of atrial fibrillation
    Hall, M
    Kirubakaran, S
    Peters, N
    Garratt, C
    HEART, 2006, 92 : A117 - A118
  • [34] Focus on vernakalant - A novel antiarrhythmic agent for the treatment of atrial fibrillation
    Dia, Ederlyn Q.
    Rathbun, Robert A.
    Song, Jessica C.
    FORMULARY, 2007, 42 (08) : 475 - +
  • [35] Novel Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation: Current Perspective
    Nakaya, Haruaki
    JOURNAL OF ARRHYTHMIA, 2011, 27 (02) : 156 - 157
  • [36] The Funny Current (If): Is it a Novel Antiarrhythmic Target to Treat Atrial Fibrillation?
    Xue, Xiaolin
    Yan, Gan-Xin
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (02) : 207 - 208
  • [37] Targeting the Vascular Endothelial Barrier to Prevent Nanoscale Cardiac Remodeling: A Novel Strategy to Prevent Atrial Fibrillation
    Mezache, Louisa
    Greer-Short, Amara
    Radwanski, Przemyslaw
    Hund, Thomas J.
    Veeraraghavan, Rengasayee
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 154A - 154A
  • [38] Angiotensin II receptor blockers in the prevention of atrial fibrillation
    Barra, Silvia
    Silvestri, Nunzia
    Vitagliano, Giancarlo
    Madrid, Alfredo
    Gaeta, Giovanni
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (09) : 1395 - 1411
  • [39] GENETIC POLYMORPHISMS OF ANGIOTENSIN II TYPE 1 RECEPTOR AND THE DEGREE OF LEFT ATRIAL REMODELING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Kim, Sook Kyoung
    Joung, Boyoung
    Shin, Dong Jik
    Park, Jae Hyung
    Kim, Jeung Min
    Lee, Moon Hyung
    Jang, Yang Soo
    Pak, Hui-Nam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E92 - E92
  • [40] Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients
    Yamagishi, S. -I.
    Matsui, T.
    Nakamura, K.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (09) : 640 - 644
12345